Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation

NCT02180477 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02180477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02180477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation
Lead sponsor
Boehringer Ingelheim
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2001
Completion date
Not reported
Enrollment
9 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy